This study aims to evaluate the use of r-metIFN-Con1 in patients with chronic hepatitis B virus infection. The purpose is to assess the tolerability of the medication at three dose levels in patients and to test the immunogenicity of the drug.
Showing the most recent 10 out of 871 publications